Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glucorecs was a private U.S. health technology and medical device company developing non-invasive blood glucose monitoring products for people with diabetes and prediabetes. Its lead product was GluFit, a finger-worn personal care glucometer intended to measure glucose without fingersticks, using patented RF and dielectric spectroscopy-based sensing technology. Publicly available profiles describe the company as focused on mobile, tabletop, and wearable applications for non-invasive blood analyte detection rather than a traditional drug pipeline. The company appears to have remained at an early development stage with preclinical and limited human testing references, and multiple business databases now list it as closed. It does not appear to have been publicly traded or acquired.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glucorecs.